阳光肺科
微信扫码登录
42
10
11万
V5
参考文献 1. FDA approves olaparib with abiraterone and prednisone (or prednisolone) for BRCA-mutated metastatic castration-resistant prostate cancer. News release. FDA. May 31, 2023.
使用道具 举报
给我们建议|手机版|PIME|阳光肺科 ( 粤ICP备2020077405号-1 )
GMT+8, 2024-9-20 15:40
Powered by Discuz! X3.5
© 2001-2024 Discuz! Team.